Correlation Between DiaMedica Therapeutics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on DiaMedica Therapeutics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Corvus Pharmaceuticals.
Diversification Opportunities for DiaMedica Therapeutics and Corvus Pharmaceuticals
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Corvus is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Corvus Pharmaceuticals
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.94 times more return on investment than Corvus Pharmaceuticals. However, DiaMedica Therapeutics is 1.06 times less risky than Corvus Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 551.00 in DiaMedica Therapeutics on November 2, 2024 and sell it today you would earn a total of 34.00 from holding DiaMedica Therapeutics or generate 6.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Corvus Pharmaceuticals |
DiaMedica Therapeutics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Corvus Pharmaceuticals
The main advantage of trading using opposite DiaMedica Therapeutics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Corvus Pharmaceuticals vs. Surrozen | Corvus Pharmaceuticals vs. Armata Pharmaceuticals | Corvus Pharmaceuticals vs. Pasithea Therapeutics Corp | Corvus Pharmaceuticals vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |